This is a correction notice. See the corrected protocol.

Correction Notice: Establishment of Human PD-1/PD-L1 Blockade Assay Based on Surface Plasmon Resonance (SPR) Biosensor

 (*contributed equally to this work, § Technical contact) Published: Aug 20, 2023 DOI: 10.21769/BioProtoc.4844 Views: 786

Reviewed by: Anonymous reviewer(s)

download pdf PDF PDF
ask Ask a question
How to cite
Favorite
Cited by

Advertisement

Bio-protocol welcomes Protocols in Bioinformatics and Computational Biology
Presubmission Inquiry

Protocol Collections

Comprehensive collections of detailed, peer-reviewed protocols focusing on specific topics

Cancer Research
Immunology
Developmental Biology
Microbiology
Neuroscience
Cell Imaging - A Special Collection for Cell Bio 2023

In the Background section of “Establishment of Human PD-1/PD-L1 Blockade Assay Based on Surface Plasmon Resonance (SPR) Biosensor" (https://bio-protocol.org/e4765), “Alsaab et al., 2018” is incorrectly referenced. The correct citation is “Alsaab et al., 2017”. The sentence should read as follows: “Clinical data have demonstrated that the blockade of PD-1 or PD-L1 can boost T cell–mediated antitumor responses, generates durable clinical responses, and prolongs patient survival time (Ohaegbulam et al., 2015; Alsaab et al., 2017).”

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A